GHK-Cu
Regulatory status · United States · as of October 2026
Not an approved drug. Topical use is regulated as a cosmetic ingredient. The injectable form was removed from 503A Category 2 on April 15, 2026, and is scheduled for review by the advisory committee at a meeting before the end of February 2027. It is not on the 503A Bulks List.
Source: FDA 503A Bulks List · PCAC meeting records · verified October 2026
Researched forSkin aging, wound healing, hair growth, gene expression modulation.
Full profile: GHK-Cu →